67
Participants
Start Date
March 31, 2013
Primary Completion Date
May 18, 2020
Study Completion Date
November 18, 2020
BT524 (Part I)
Single intravenous infusion of 70 mg BT524 per kg body weight.
BT524 (Part II)
Single or repetitive intravenous infusion(s) of BT524, depending on the severity of the disorder, location and extent of the bleeding and patient's clinical condition. Dosage based on individual body weight and fibrinogen level.
Site 15, Sofia
Site 11, Cairo
Site 16, Frankfurt
Site 01, Beirut
Site 14, Sousse
Site12, Tunis
Lead Sponsor
Collaborators (3)
ICON plc
INDUSTRY
Phoenix Clinical Research
OTHER
Accovion GmbH
INDUSTRY
Biotest
INDUSTRY